Intratumoral IDH1 mutation status in intrahepatic cholangiocarcinoma is homogeneous
{{output}}
Introduction: IDH1 mutations occur in approximately 10%-20% of intrahepatic cholangiocarcinoma (iCCA) and constitute an established target for molecularly guided therapy. As routine molecular diagnostics are commonly based on a s... ...
